: What is the implication of aberrant CD24 expressions in endometriosis (EM) and the relevant mechanisms?
: Thirty women with EM and twenty-seven women with other benign gynecological diseases, who underwent laparoscopy and hysteroscopy, were recruited in this study. The hEM15A cells were used in functional experiments in vitro. The microarray assay and bioinformatics analyses were performed to investigate the differentially expressed genes (DEGs) and signaling pathways regulated by CD24.
: CD24 was expressed at significantly higher levels in eutopic endometrial (EU) tissues than in paired ectopic endometrial (EC) tissues from EM patients and normal endometrial (NE) tissues from controls. However, the CD24 expressions had no obvious relationships with clinical features such as age, infertility conditions, and menstrual cycle phase. Suppression of CD24 by small interfering RNAs in hEM15A cells impaired cell migration and reduced cytoskeletal filamentous actin (F-actin), but had no effects on cell apoptosis, cell cycle or cell viability. A total of 862 DEGs were identified between siCD24 and siNC, which consisted of 517 upregulated genes and 345 downregulated genes. The gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses for the DEGs mainly focused on the type I interferon signaling pathway and TGF-beta signaling pathway. Gene set enrichment analysis (GSEA) was also conducted. Furthermore, a protein-protein interaction (PPI) network and subnetwork were constructed to explore the hub modules and DEGs.
: This study provides a better understanding of the role of CD24 in EM.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Reproductive BioMedicine Online
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Xiaohong Chang is Professor at Department of Obstetrics and Gynecology in Peking University People's Hospital. She has been working on the clinical and basic research into endometriosis and ovarian cancer for years.
Accepted: December 21, 2022
Received in revised form: November 28, 2022
Received: August 23, 2022
Publication stageIn Press Journal Pre-Proof
© 2022 Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.